一种氨酸衍生物大致通过病毒蛋白酶抑制抑制冠状病毒复制
Katrina Forrestall1, Eric S Pringle2, Dane Sands1
1Department of Medicine (Geriatric Medicine and Neurology) and Medical Neuroscience, Dalhousie University, 5850 College Street, Halifax, NS, Canada, B3H 4R2.
Antiviral research
|November 26, 2023
概括
一种新型的氨酸衍生物可有效抑制关键的冠状病毒蛋白酶,包括SARS-CoV-2主要蛋白酶 (Mpro) 和帕帕因类蛋白酶 (PLpro). 这种化合物对多种人类冠状病毒具有广泛的抗病毒活性,抑制了早期的病毒复制.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 生物化学 生化学
背景情况:
- 冠状病毒的复制依赖于病毒蛋白酶的聚蛋白分裂.
- 人类冠状病毒 (HCoV) 使用主要蛋白酶 (Mpro) 和类似帕帕因的蛋白酶 (PLpro) 来完成这一重要步骤.
- 抑制这些蛋白酶是一种潜在的抗病毒策略.
研究的目的:
- 确定和描述HCoV Mpro和PLpro. 的抑制剂.
- 评估针对各种冠状病毒的已识别的抑制剂的广泛抗病毒活性.
主要方法:
- 使用结构导向药物设计来识别一种氨酸衍生物.
- 在式对接研究中预测了与SARS-CoV-2,HCoV-229E和HCoV-OC43.3的Mpro和PLpro活性部位的结合.
- 使用纤维素测试来评估抗病毒活性和作用机制.
主要成果:
- 鉴定出一种表氨酸衍生物,可以抑制SARS-CoV-2 Mpro和PLpro.
- 在体研究中证实了对来自HCoV-229E和HCoV-OC43.3的蛋白酶的潜在结合.
- 该化合物对测试的HCoVs表现出广泛的抗病毒活性,抑制了早期的病毒复制和器官细胞形成.
结论:
- 西尿素衍生物代表了对冠状病毒的广谱抗病毒药物的有前途的类别.
- 这种化合物的病毒蛋白酶抑制有效地破坏了早期的复制阶段.
- 这种方法可能为打击各种冠状病毒感染提供一种策略.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
303
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
303
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
576
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
576


